SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 21.69 |
| Enterprise Value ($M) | 17.55 |
| Book Value ($M) | 3.57 |
| Book Value / Share | 0.22 |
| Price / Book | 6.07 |
| NCAV ($M) | 3.54 |
| NCAV / Share | 0.21 |
| Price / NCAV | 6.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.15 |
| Return on Assets (ROA) | -1.25 |
| Return on Equity (ROE) | -1.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.11 |
| Current Ratio | 6.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.23 |
| Assets | 4.27 |
| Liabilities | 0.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Bay Shore Trust | 31.01 | -4.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 100,073 | 229,966 | 43.52 | |
| 171,238 | 545,699 | 31.38 | |
| 98,086 | 338,411 | 28.98 | |
| 136,575 | 438,228 | 31.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MBRX – Moleculin Biotech, Inc. | ME – 23andMe Holding Co. |
| MEIP – MEI Pharma, Inc. | MLTX – MoonLake Immunotherapeutics |
| MNPR – Monopar Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io